|
Publications
In this section we provide you information about important publications
and abstracts authored by Dr. Edwards in many scientific journals in the last two years. This section is regularly
updated.
1. Goodman A, Brown T, Edwards K, Krupp L, Schapiro R, Cohen R, Marinucci L, Blight A. A Confirmatory Phase 3 Trial of
Sustained Release Oral Fampridine in Multiple Sclerosis. Neurology 2009:
Submitted
2. Glantz M, Chamberlain M, Liu Q, Hsieh C, Edwards K, Horn A, Recht L. Gender disparity in the rate of partner abandonment
in patients with serious medical illness. Cancer 2009 115:5237-5242.
Click here to view article
3. Cohen J, Imrey P, Calabresi P, Edwards K, Eikenhorst T, Felton III W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton
G, Mandell B, Scott T, Zang H, Apperson-Hansen C, Beck G, Houghtaling P, Karafa M, Stadtler M. Results of the Avonex Combination
Trial (ACT) in relapsing-remitting MS. Neurology 2009 72:535-541.
Click here to view article
Listed below are the Oral and Poster abstracts presented at the 25 th Congress of the European Committee for Treatment
and Research in Multiple Sclerosis (ECTRIMS) September 9-12, 2009 Dusseldorf, Germany
4. Edwards K, Goodman W, Button A. Fampridine-SR for cognitive improvement in Multiple Sclerosis. Multiple Sclerosis 2009 15:S18.
Click here to view ECTRIMS oral presentation abstract.
5. Edwards K, Goodman W, Wilken J, Cane R, Sullivan C. Neuropsychological evaluation in patients with relapsing-remitting
multiple sclerosis: development and validation of a computerized model. Multiple Sclerosis 2009 15:S230.
Click here to view ECTRIMS poster presentation abstract
6. Connor G,
Edwards K, Tarsy D. Topiramate in Essential Tremor: Findings from Double-Blind, Placebo-Controlled,
Crossover Trials. Clin Neuropharmacol 2008 Mar-Apr;31(2):97-103
.
7. Phillips J, Weinstock-Guttman
B, Felton W, Englis J, Rossman H, Edwards K, Honeycutt W, Sheremata W. A
Multicenter, Open-label, Crossover Study of Safety, Tolerability, and Patient preference for a Single-Use Autoinjector
vs Manual Injection of Intramuscluar Interferon Beta-1a in Patients with Multiple Sclerosis. Inter Jour of MS Care.: In Press
|
